Follow-up of long-term treatment of predialysis renal bone disease with 1-α-hydroxy-derivatives of vitamin D
- 1 July 1983
- journal article
- clinical trial
- Published by Elsevier in Journal of Steroid Biochemistry
- Vol. 19 (1) , 511-516
- https://doi.org/10.1016/0022-4731(83)90211-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- SERUM CONCENTRATIONS OF METABOLITES OF VITAMIN D IN PATIENTS WITH CHRONIC RENAL FAILURE (CRF). CONSEQUENCES FOR THE TREATMENT WITH 1‐α‐HYDROXY‐DERIVATIVESClinical Endocrinology, 1981
- Intestinal calcium absorption, serum phosphate, and parathyroid hormone in patients with chronic renal failure and osteodystrophy before and during hemodialysisCalcified Tissue International, 1978
- CORRELATION OF CLINICAL, BIOCHEMICAL AND SKELETAL RESPONSES TO l α -HYDROXYVITAMIN D3IN RENAL BONE DISEASEClinical Endocrinology, 1977
- Methyl‐methacrylate as an embedding medium in histopathologyHistopathology, 1977
- VARIABLE RESPONSE TO LONG-TERM 1α-HYDROXYCHOLECALCIFEROL IN HÆMODIALYSIS OSTEODYSTROPHYThe Lancet, 1976
- Action of 1,25-Dihydroxycholecalciferol, a Potent, Kidney-Produced Metabolite of Vitamin D3, in Uremic ManNew England Journal of Medicine, 1972
- Quantitative histology of metabolic bone diseaseClinics in Endocrinology and Metabolism, 1972
- Quantitative structural analysis of human cancellous boneCells Tissues Organs, 1970
- A quantitative histological study on bone formation in human cancellous boneCells Tissues Organs, 1970
- A quantitative histological study on bone resorption in human cancellous boneCells Tissues Organs, 1969